Product Portfolio

Poultry

www.shinilpharma.com www.pf.com.bd
 Product Portfolio
Jla Dcv`vb wb‡`©kbv gvÎv I cÖ‡qvMwewa mieivn
NUTRITIONAL & METABOLICS
gyiwMi †h †Kvb ai‡bi aKj KvwU‡q DV‡Z `ªæZ 1 wjUvi cvwb‡Z 50 MÖvg cvDWvi fvj
cÖwZ MÖvg cvDWv‡i i‡q‡Q Møy‡KvR 980 mnvqZv K‡i, ev”Pv gyiwMi Zvr¶wYK kw³`vqK K‡i wgwk‡q wb‡Z n‡e| ev”Pvi eªæwWs 100 MÖvg
Royal GC WSP wg.MÖv. wfUvwgb wm 20wg.MÖv.| wn‡m‡e KvR K‡i, cwienY I Ab¨vb¨ aKjRwbZ
i‡qj wRwm WweøDGmwc ïiæ Kivi cÖ_g 24 N›Uv a‡i i‡qj 500 MÖvg
g„Zz¨ nvi Kgvq, Zxeª Mig RwbZ `Lj †_‡K iÿv wRwm WweøDGmwc LvIqv‡Z n‡e|
K‡i, wnU ÷ªK cÖwZ‡iva K‡i|

¯œvqyweK `ye©jZv, Kvj©W-†Uv c¨vivjvBwmm (cv I

cÖwZ MÖvg cvDWv‡i i‡q‡Q
Royal B-3 WSP wfUvwgb we1 (_vqvwgb) - 50 wg.MÖv.
i‡qj we-3 WweøDGmwc wfUvwgb we2 (wi‡evd¬vwfb) - 10 wg.MÖv.
wfUvwgb we6 (cvBwiWw·b) - 20 wg.MÖv.
cv‡qi bL euvKv n‡q hvIqv), †bK c¨vivjvBwmm 1 MÖvg/wjUvi Lvevi cvwb‡Z wgwk‡q 5
(Nvo euvKv), DBs c¨vivjvBwmm (cvLbv †e‡K w`b LvIqv‡Z n‡e|
100 MÖvg
hvIqv), ˆ`wnK e„w× K‡g hvIqv, Drcv`b e¨vnZ A_ev 10 MÖvg cÖwZ 4-5 †KwR Lv‡`¨
nIqv BZ¨vw` †iv‡Mi cÖwZ‡iva I wPwKrmvq wgwk‡q 5 w`b LvIqv‡Z n‡e|
e¨envh©|

cvwb‡Z `ªebxq gvwëwfUvwgb I A¨vgvB‡bv GwmW 0.5-1 MÖvg 1 wjUvi Lvevi cvwb‡Z
Royal-Vitaplex WSP 14 wU wfUvwgb I 2 wU A¨vgvB‡bv
wgwkÖZ wcÖwg· hv kvixwiK MVb I my¯^v¯’¨ eRvq wgwk‡q 3-5 w`b A_ev 1 †KwR
GwmW mg„× wcÖcv‡ikb| 100 MÖvg
i‡qj-wfUv‡cø· WweøDGmwc †i‡L Drcv`b ÿgZv e„w× K‡i| Lvev‡ii mv‡_ LvIqv‡Z n‡e|

†ivM cÖwZ‡iva ÿgZv e„w× K‡i, f¨vKwm‡bi

eªqjv‡i 1g, 2q I 3q mßv‡n 1000
Kvh©KvwiZv e„w× K‡i, Gw›Ue¨vK‡Uwiqvj I
SI Lysolex cÖwZ 100 Mªv‡g jvB‡mvRvBg Av‡Q
Gw›UBbd¬¨v‡gUix Kvh©KvwiZv cÖ`k©b K‡i,
gyiMxi ev”Pvi Rb¨ h_vµ‡g 10 MÖv., 50 MÖvg
GmAvB jvB‡mv‡j· 3500 BDwbU| 20 MÖv., I 35 MÖv. Ges †jqv‡i 35 100 MÖvg
g¨v÷vBwUm cÖwZ‡iv‡a mnvqZv K‡i Ges Wvqwiqv
MÖv. cici 2 w`b LvIqv‡Z n‡e|
cÖwZ‡iva K‡i|

cÖwZ †KwR‡Z Av‡Q - wjfvi G·Uªv± 15 wjfv‡ii Kvh©ÿgZv e„w× K‡i| wjfv‡ii ÿwZMÖ¯’
†Kvlmg~n‡K †givgZ K‡i †gUvewjK I Miæ/gwnl: 25 MÖvg/ cÖvYx/ w`b|
MÖvg, UªvB‡Kvwjb mvB‡UªU 20 MÖvg, evQzi/ QvMj /†fov: 5-10 MÖvg/ cÖvYx/
SI LIVOPRO Powder B‡bvwmUj 5 MÖvg, wWGj-wgw_Iwbb 30 WvB‡Rw÷f wm‡÷‡gi Kvh©ÿgZv e„w× K‡i| 200 MÖvg
wjfvi‡K eûwea aK‡ji nvZ †_‡K iÿv K‡i| w`b|
GmAvB wj‡fv‡cÖv cvDWvi MÖvg, wfUvwgb wm 5 MÖvg, wfUvwgb we12 wjfvi A‡K‡Rv nIqv I d¨vwU wjfvi wmb‡Wªvg Gi †cvwëª: 1 MÖvg/ 2 wjUvi Lvevi cvwb‡Z m¨v‡k
300 MÖvg, wbqvwmb 5 MÖvg I †m‡jwbqvg cÖv`yf©ve Kwg‡q †`q| K…wgbvkK, Gw›Uev‡qvwUK I gvQ: 2-3 MÖvg/†KwR Lv‡`¨ 5-7 w`b|
100 wgwjMÖvg| f¨vKwmb e¨env‡ii ci e¨envi Kiv hvq|
cÖwZ †KwR‡Z Av‡Q K¨vjwmqvg-240
Incal-P MÖvg, dmdivm-120 MÖvg, wfUvwgb †cÖvjvcm K¬‡qKv I K¨vwbevwjRg cÖwZ‡iva K‡i, 1 MÖvg 1 wjUvi Lvevi cvwb‡Z wgwk‡q
wW3-120000 AvB.BD., dvB‡UR- nvo MV‡b mnvqZv K‡i, wW‡gi Drcv`b e„w× K‡i| 5-7 w`b LvIqv‡Z n‡e| 500 MÖvg
BbK¨vj-wc
100000 AvB.BD.|
cÖwZ wg.wj. †Z Av‡Q
wfUvwgb we1 - 500 wg.MÖv
wfUvwgb we2 - 200 wg.MÖv. †cÖvwUb, d¨vU Ges wbDwK¬K GwmW Gi wecv‡K Miæ/†Nvov- 40 wg.wj./cÖvYx‡Z cici 100 wg.wj.
wfUvwgb we6 - 200 wg.MÖv. mvnvh¨ K‡i, wjfvi‡K welwµqv †_‡K myiÿv K‡i, 2-3 w`b|
wfUvwgb we12 - 10 wg.MÖv. 500 wg.wj
SI LIV Oral Liquid GwU d¨vwU wjfvi wmb‡Wªvg cÖwZ‡iva Ges QvMj/†fov- 10-15 wg.wj. / cÖvYx‡Z 1 wjUvi
K¨vjwmqvg †cb‡Uvw_‡bU-500 wg.MÖv. gvB‡KvUw·b‡K wbw®Œq K‡i, K…wgbvkK I cici 2-3 w`b|
GmAvB wjf Iivj wjKzBW 5 wjUvi
wb‡KvwUbvgvBW - 2000 wg.MÖv. Gw›Uev‡qvwUK e¨env‡ii ci ˆ`wnK e„w× mgybœZ †cvwëª- 1 wg.wj. / 1-2 wjUvi Lvevi 10 wjUvi
B‡bvwmUj - 100 wg.MÖv. iv‡L| cvwb‡Z cici 3-5 w`b|
†Kvwjb †K¬vivBW - 5000 wg.MÖv. 20wjUvi
dwjK GwmW - 30 wg.MÖv.
wWGj-wgw_Iwbb - 1000 wg.MÖv.
Aw¯’mwÜ dz‡j hvIqv I k³ nIqv, wi‡KUm, ÎæwUc~Y© †cvwëª: 1 wg.wj. 1 wjUvi Lvevi cvwbi
nv‡oi MVb I big †VuvU, QÎvKRwbZ †iv‡Mi cÖ‡Kvc mv‡_ wgwk‡q 3-5 w`b LvIqv‡Z n‡e|
cÖwZ 100 wg.wj. †Z i‡q‡Q wfUvwgb Mev`x cÖvYx: cÖ_‡g 200 wg.wj. I
SI Dipro wW3 5,00,000 AvBBD I †cÖvcvBwjb
n«vm, big I cvZjv wW‡gi †Lvmv BZ¨vw` cÖwZ‡iv‡a 100 wg.wj.
GmAvB wW‡cÖv mn‡hvMx wn‡m‡e e¨envh©| wK‡Uvwmm, wgé wdfvi, cieZ©x‡Z 100 wg.wj. K‡i w`‡b `yBevi 500 wg.wj.
MøvBKj 100 wg.wj. ch©šÍ| K¨vjwmqvg I dmdiv‡mi AfveRwbZ †ivM cici 2 w`b| wK‡Uvwmm I wgé wdfvi
cÖwZ‡iv‡ai Rb¨ ev”Pv cÖm‡ei ci w`‡b
cÖwZ‡iva I wPwKrmvi mn‡hvMx wn‡m‡e e¨envh©| 100 wg.wj. K‡i 10 w`b LvIqv‡Z n‡e|
Wvqwiqvi mn‡hvMx wPwKrmv wn‡m‡e, BwgDwbwU e„w× †cvwëªi †¶‡Î, cÖwZ‡iv‡a: 2 wg.wj. 100 wg.wj.
cÖwZ 5 wg.wj. †Z Av‡Q wRsK mvj‡dU Ki‡Z, gyiwMi cvjK cov Kgv‡Z Ges bZzb cvjK wPwKrmvq: 3 wg.wj. cÖwZw`b, cici 500 wg.wj
Shizinc Solution g‡bvnvB‡W«U BDGmwc hv 10 wg.MÖv. MRv‡Z, wW‡gi Drcv`b I n¨vPvwewjwU e„wׇZ, 5-7 w`b| eo cÖvYxi †¶‡Î- 50-100 1 wjUvi
wmwR¼ mwjDkb Gwj‡g›Uvj wRsK Gi mgZyj¨| Aw¯’mwÜ †dvjv Ges nvBcviK¨viv‡Uvwmm †iva Ki‡Z wg.wj. †QvU cÖvYxi †¶‡Î- 25-30 5 wjUvi
I iæwP e„wׇZ, †U÷evW‡K DbœZ K‡i I iæwP e„w× wg.wj. †cvlv cÖvYxi †¶‡Î- 3-5 10 wjUvi
K‡i, Mev`x cÖvYxi LSD cieZ©x ¯‹xb wi‡Kvfvix| wg.wj. cÖwZw`b, cici 5-7 w`b| 20wjUvi
cÖwZ‡iv‡a- 1 wg.wj. cÖwZ 2-3 wjUvi
†cvwëªi Wvqwiqv cÖwZ‡iva K‡i, Mevw` cÖvYx I
cÖwZ 100 wg.wj. †Z Av‡Q- Lvevi cvwb‡Z cici 3-5 w`b| 100 wg.wj.
†cvwëªi iæwP e„w× K‡i, wWg I gvsm Drcv`b e„w×
wRsK - 200 wg.MÖv. wPwKrmvq- 1 wg.wj. cÖwZ 1 wjUvi 500 wg.wj
K‡i, evQzi I eªqjvi gyiwMi ˆ`wnK IRb m‡e©v”P
Shizinc Plus Solution _vqvwgb nvB‡Wªv‡K¬vivBW - 500 wg.MÖv. Lvevi cvwb‡Z cici 3-5 w`b| 1 wjUvi
e„w× K‡i, †cvwëªi aKj Kgvq I cvjK Siv
wmwR¼ cøvm mwjDkb wi‡evd¬vwfb (wfUvwgb we2) - 150 wg.MÖv. Mevw` cÖvYx- 20-30 wg.wj. cÖwZ 5 wjUvi
cÖwZ‡iva K‡i, †ivM cÖwZ‡iva ÿgZv e„w× K‡i|
cvBwiWw·b nvB‡Wªv‡K¬vivBW - 800 wg.MÖv. cÖvYxi Rb¨ cici 3-5 w`b| 10 wjUvi
Mev`x cÖvYxi LSD cieZ©x ¯‹xb wi‡Kvfvix, †cvlv
wb‡KvwUbvgvBW - 400 wg.MÖv. evQzi- 10-15 wg.wj. cÖwZ cÖvYxi Rb¨ 20wjUvi
cÖvYxi Wvg©v‡UvdvB‡Uvwmm, BwgDwbwU e„w×|
cici 3-5 w`b|
wfUvwgb-B Ges †m‡jwbqv‡gi NvUwZ c~i‡Y, Mf©ve¯’vq, †cvwëª: wPwKrmvq- 1 wg.wj./2 wj.
cÖwZ wg.wj. †Z Av‡Q wfUvwgb-B 100 `y»`vbKvix Ges evošÍ cÖvYx‡`i †ÿ‡Î, †nvqvBU gvmj LvIqvi cvwb‡Z 5-10 w`b|
Shisel-E Solution wg.MÖv. Ges †mvwWqvg †m‡jbvBU 0.5 wWwRR, GbRywUK c¨vivjvBwmm, †µwR wPK wWwRR, cÖwZ‡iv‡a-1 wg.wj./4 wj. LvIqvi 100 wg.wj.
wm‡mj-B mwjDkb wg.MÖv.| Gb‡mdv‡jvg¨vjvwmqv, Gw·D‡WwUf Wvqvw_wmm, cvwb‡Z 5-10 w`b| 500 wg.wj.
A¨vmvBwUm cÖwZ‡iva I wPwKrmvq, wW‡gi Drcv`b, Mevw` cÖvYx: 1-2 wg.wj./10 †KwR
n¨vPvwewjwU, A¨vw›UewWi Drcv`b I †ivM cÖwZ‡iva ÿgZv e„w×| ˆ`wnK IR‡bi Rb¨ 5-10 w`b|
 Product Portfolio
Jla Dcv`vb
NUTRITIONAL & METABOLICS
cÖwZ wg.wj. †Z Av‡Q
†divm mvj‡dU-50 wg.MÖv.
SI Iron Solution †Kvevë (mvj‡dU)-10 wg.MÖv.
GmAvB Avqib mwjDkb Kcvi mvj‡dU-20 wg.MÖv.
wRsK mvj‡dU-20 wg.MÖv.
wfUvwgb we12 10 wg.MÖv./ 100 wg.wj.
cÖwZ wjUv‡i Av‡Q
†mvwWqvg †K¬vivBW - 100 MÖvg
cUvwkqvg †K¬vivBW - 33 MÖvg
K¨vjwmqvg †K¬vivBW - 12.7 MÖvg
g¨vM‡bwmqvg †K¬vivBW - 4.8 MÖvg
Vitalyte Solution Møy‡KvR - 300 MÖvg
wfUvjvBU mwjDkb MøvBwmb - 80 MÖvg
wfUvwgb we2 - 1 MÖvg
wfUvwgb we6 - 1 MÖvg
wfUvwgb we12 - 2.5 MÖvg
mvBwUªK GwmW - 10 MÖvg
SI BG
cÖwZ wjUv‡i Av‡Q Gj KviwbwUb - 50
MÖvg, we‡UBb nvB‡Wªv‡K¬vivBW - 200
Vigotonic Solution MÖvg, wW miweUj - 100 MÖvg,
wf‡MvUwbK mwjDkb g¨vM‡bwmqvg mvj‡dU nvB‡WªU - 100
250mL
MÖvg, †Kvwjb †K¬vivBW - 50 MÖvg, Uwib
- 20 MÖvg|
cÖwZ wjUv‡i Av‡Q - GgvB‡jR
2500000 BDwbU, jvB‡cR 25000
SI Liquizyme BDwbU, RvBjv‡bR 250000 BDwbU,
†mjy‡jR 1000000 BDwbU, †cw±‡bR
Gm AvB wjKzBRvBg
30000 BDwbU, dvB‡UR 20000
BDwbU, Gw·wc‡q›U wKDGm|
cÖwZ 10 wg.wj. †Z Av‡Q
Kcvi mvj‡dU 50 wg.MÖv., †Kvevë
†KøvivBW 1 wg.MÖv., †divm mvj‡dU
300 wg.MÖv., g¨vM‡bwmqvg mvj‡dU
100 wg.MÖv., g¨v½vwbR mvj‡dU 800
SI MINVET wg.MÖv., wRsK mvj‡dU 800 wg.MÖv.,
GmAvB wgb‡fU cUvwmqvg Av‡qvWvBW 30 wg.MÖv.,
†mvwWqvg †m‡jbvBU 100 gvB‡µvMÖvg,
wWGj-wgw_Iwbb 300 wg.MÖv.,
Gj-jvBwmb 325 wg.MÖv., †Kvwjb
†KøvivBW 315 wg.MÖv.|
cÖwZ 10 wg.wj. †Z Av‡Q †Kvwjb
†K¬vivBW- 1250 wg.MÖv., wW Gj
wgw_Iwbb-300 wg.MÖv., Gj
Inliv jvBwmb-100 wg.MÖv., wfUvwgb we12-30
Bbwjf gvB‡µv MÖvg, ev‡qvwUb-100 gvB‡µv
MÖvg, wfUvwgb B-50 wg.MÖv., miweUj-
600 wg.MÖv., wjfvi d«vKkb-100
wg.MÖv., B÷ G·Uªv±-300 wg.MÖv.|
cÖwZ wg.wj. †Z Av‡Q K¨vjwmqvg j¨vK‡UU
150 wg.MÖv., K¨vjwmqvg Mø‡y Kv‡bU-100
Incal-Vet wg.MÖv., K¨vjwmqvg dm‡dU UªvB‡ewmK-
BbK¨vj-†fU 70 wg.MÖv., wfUvwgb wW3-250 AvB. BD.,
wfUvwgb we12-5 gvB‡µv MÖvg, †Kvwjb
†K¬vivBW-100 wg.MÖv.|
cÖwZ 10 wg.wj. †Z i‡q‡Q-
Kvifv‡µvj, Pv Mv‡Qi †Zj, cyw`bv
OREGANOMIX
†Zj/†gb_j, cvBwbb, imy‡bi wbh©vm,
AwiMv‡bvwg·
_vBg †Zj, †gŠwi †Zj, wj‡gvwbb,
Uviwc‡bvwjb|
cÖwZ wjUv‡i Av‡Q wfUvwgb G 800000
AvB. BD., wfUvwgb wm 1000 wg.MÖv.,
we‡UBb 5000 wg.MÖv., Gj-jvBwmb
3000 wg.MÖv., wgw_Iwbb 400 wg.MÖv.,
SUPLEXAN Ren MviwjK I‡qj 800 wg.MÖv., †Mv‡ìb iU
wUsPvi 30000 wg.MÖv., nm©‡UBj wUsPvi
mvc‡j‡·b †ib 30000 wg.MÖv., Kgb wbUj G·Uªv±
30000 wg.MÖv., weªR wUsPvi 30000
wg.MÖv., Bgvjwmdvqvi 25 MÖvg, cUvwkqvg
mi‡eU 2000 wg.MÖv., I Gw›U Aw·‡W›U|
wb‡`©kbv gvÎv I cÖ‡qvMwewa mieivn
Mev`x cÖvYx, †cvwëª I †cvlv cÖvYxi i³¯^íZv,
†cvwëª: 1 wg.wj./wjUvi Lvevi cvwb‡Z 100 wg.wj.
†jvgd¨vKv‡k I S‡i hvIqv cÖwZ‡iv‡a e¨envi nq|
cici 3-5 w`b| 500 wg.wj.
GQvovI †cvwëªi †ivM cÖwZ‡iva ÿgZv, wWg
Miæ/†Nvov- 1wg.wj./†KwR ˆ`wnK 1 wjUvi
Drcv`b, ˆ`wnK e„w× I n¨vPvwewjwU e„wׇZ AZ¨šÍ
IR‡bi Rb¨ cici 2-3 w`b|
Kvh©Ki|
cvwbk~b¨Zv, cvZjv cvqLvbv I
1-2 wg.wj. 1 wjUvi Lvevi cvwb‡Z
Hypoglycemia Gi mnvqK wPwKrmvq e¨envi wgwk‡q 5-7 w`b LvIqv‡Z n‡e| 500 wg.wj.
Kiv nq| wnU‡÷ªvK cÖwZ‡iva K‡i|
†cvwëª: 1-2 wg.wj. 1 wjUvi Lvevi cvwb‡Z
wW‡gi Drcv`b e„w× K‡i, wjfv‡i AwZwi³ Pwe© wgwk‡q 5-10 w`b LvIqv‡Z n‡e| 100 wg.wj.
Rg‡Z evav †`q, mKj ai‡Yi †÷ªm cÖwZ‡iva K‡i, Miæ/gwnl/‡Nvov: cÖwZ cÖvYx‡Z 20-30
wg.wj. K‡i ci ci 7-10 w`b| 500 wg.wj.
ZvrÿwYK kw³ cÖ`vb K‡i|
evQyi/†fov/QvMj: cÖwZ cÖvYx‡Z 10-15
wg.wj. K‡i ci ci 7-10 w`b|
Lvev‡ii Pvwn`v e„w× K‡i ˆ`wnK IRb evovq,
Lvev‡ii m‡e©v”P e¨envi wbwðZ K‡i, A‡š¿ cywó
100 wg.wj.
Dcv`v‡bi m‡e©v”P †kvlY wbwðZ K‡i, wW‡gi
1 wg.wj. cÖwZ 1-2 wjUvi cvwb‡Z|
Drcv`b evovq Ges †Lvmv k³ K‡i, bb÷vP© 500 wg.wj.
cwjm¨vKvivBW‡K †f‡½ †kvlY‡hvM¨ Dcv`v‡b 1 wjUvi
cwiYZ K‡i|
wW‡gi †Lvmvi ¸YMZ gvb Ges wW‡gi Drcv`b
e„w× K‡i| †cvwëªi †ivM cªwZ‡iva ÿgZv e„w×
K‡i| ˆ`wnK IR‡bi ¯^vfvweK e„w× I e„w×i nvi
ˆ`wbK 1-2 wg.wj./wjUvi cvwbi mv‡_ 250 wg.wj.
mgybœZ iv‡L| gvsm †ckxi `ye©jZv cÖwZ‡iv‡a
wgwk‡q 7-10 w`b A_ev cÖwZ 100 500 wg.wj.
Ges cvj‡Ki mylg e„wׇZ Kvh©Ki| wnU †÷ªm ev
†gviM-gyiwMi Rb¨ 12-15 wg.wj.| 1 wjUvi
Ab¨vb¨ aK‡ji d‡j m„ó Lv`¨ MÖn‡b Abxnv `~i
K‡i Ges f¨vKwm‡bk‡bi c‡i BwgDb wm‡÷g‡K
Z¡ivwš^Z K‡i|
hK…‡Zi mylg Kvh©KvwiZv e„w× K‡i| DËg ˆ`wnK
†cvwëª: 20-30 wg.wj. cÖwZ 100
e„w×, gvs‡mi AwaK Drcv`b, gvB‡KvUw·b Ges evW©m Gi Rb¨ 5-7 w`b LvIqv‡Z
d¨vwUwjfvi wmbWªg cÖwZ‡iva K‡i| Drcv`b ÿgZv
n‡e|
iÿv K‡i| Gw›Uev‡qvwUK I K…wgbvkK e¨env‡ii Miæ/†Nvov/gwnl: cÖwZw`b 40 wg.wj. 1 wjUvi
c‡i ˆ`wnK e„w× mgybœZ iv‡L| Lv‡`¨ Abxnv `~i
K‡i 5-7 w`b|
K‡i, wcËim wbtmiY K‡i| Avwgl, kK©iv, Pwe© QvMj/†fov: cÖwZw`b 15 wg.wj. K‡i
cwicvK I †gUvewjR‡g mnvqZv K‡i|
5-7 w`b|
nvo MV‡b mnvqZv K‡i I nvo ÿq †iva K‡i, †jqvi/eªqjvi: 20-24 wg.wj. /100
wW‡gi †Lvmv k³ K‡i, wWg fv½v †iva K‡i, evW©m 5-7 w`b| wPKm/†MÖvqvi: 10-15
c¨vivjvBwmm, K¨vwbevwjRg, wi‡KUm I wg.wj. /100 evW©m 5-7 w`b| 1 wjUvi
Aw÷I‡gjvwmqv cÖwZ‡iva K‡i, †jqvi gyiwM‡Z Miæ/†Nvov/gwnl: cÖwZw`b 40-50 5 wjUvi
cÖjvcm cÖwZ‡iva K‡i| wg.wj. K‡i 5-7 w`b| QvMj/†fov:
cÖwZw`b 10- 15 wg.wj. K‡i 5-7w`b|
gyiwMi Rb¨- Lvevi cvwb‡Z 5-7 w`b|
A¨vw›Ue¨vK‡Uwiqvj, A¨vw›UfvBivj, A¨vw›Udv½vj, wPK I †MÖvqvi- 1 wg.wj./wjUvi cvwb‡Z|
A¨vw›U‡Kvw·wWqvj, bb A¨vw›Uev‡qvwUK †MÖv_ eªqjvi/†jqvi/weªWvi-
cÖ‡gvUvi, A¨vw›UAw·‡W›U, A¨vw›U-Bbd¬¨v‡gUwi,
1-2 wg.wj. / wjUvi cvwb‡Z|
100 wg.wj.
BwgD‡bvgWz‡jUwi, nR‡g mvnvh¨ K‡i, A‡š¿i eo cÖvYx- 50-60 wg.wj./w`b|
c¨v‡_v‡Rb cÖwZ‡iva Ki‡Z mvnvh¨ K‡i, eªqjv‡i evQyi/†fov/QvMj- 20 wg.wj./w`b|
FCR DbœZ K‡i, †jqv‡i †÷«m Kgv‡Z Ges wW‡gi Lv‡`¨- 250-500 wg.wj./Ub Lv‡`¨|
Drcv`b evovq| KyKyi- 5 wg.wj./w`b|
Ascites, Gout, Urolithiasis cÖwZ‡iva I
cÖwZKvi K‡i| wKWwb I g~Îbvwji mKj msµgY 1 wg.wj. 1 wjUvi Lvevi cvwb‡Z wgwk‡q 500 wg.wj.
Gi weiæ‡× Kvh©Kix| Jl‡ai cvk¦© cÖwZwµqv `~i cici 3-5 w`b LvIqv‡Z n‡e|
K‡i wKWwbi ¯^vfvweK Kvh©ÿgZv iÿv K‡i|

cÖwZ wjUv‡i Av‡Q diwgK GwmW 53%, GwmwWb A‡š¿i pH Gi fvimvg¨ eRvq †i‡L DcKvix 1 wg.wj. 2 wjUvi Lvevi cvwb‡Z
ACIDIN 500 wg.wj.
dmdwiK GwmW 21.3%, mvBwUªK e¨vK‡Uwiqvi cwigvY e„wׇZ mnvqZv K‡i| wgwk‡q ci ci 3-5 w`b LvIqv‡Z
GwmW 8.6%, j¨vKwUK GwmW 4.4%| mvj‡gv‡bjv, E. coli, K¬w÷ªwWqvg e¨vK‡Uwiqv †_‡K n‡e|
GwmwWb 1 wjUvi
myiÿv †`q| ˆ`wnK e„w× I Drcv`b e„w× K‡i|
 Product Portfolio
Jla Dcv`vb wb‡`©kbv gvÎv I cÖ‡qvMwewa mieivn
NUTRITIONAL & METABOLICS
cÖwZ wg.wj. †Z Av‡Q U‡bvdm‡db-100 cwicvK ÿgZv evovq, wW‡gi Drcv`b I ˆ`wnK †cvwëª- cÖwZwU gyiwMi Rb¨ 0.2 wg.wj.
Toposal Injection wg.MÖv. wfUvwgb we12- 20 gvB‡µvMÖvg| IRb e„w× K‡i, †gUvewjRg nvo e„w× K‡i| Miæ/gwnl/†Nvov: 10-40 wg.wj., evQzi: 100 wg.wj.
U‡cvmvj Bb‡RKkb 7.5-12.5 wg.wj., QvMj/†fov: 2.5-5
wg.wj K‡i gvs‡m/ Pvgovi wb‡P|

ANTIGOUT
MvDU I i‡³ D”P gvÎvq BDwiK Gwm‡Wi wPwKrmvq:
wPwKrmvq, wKWwbi Kvh©KvixZv evov‡Z, wKWwb‡K 25 wg.MÖv. wmbj WweøDGmwc
Shinol WSP cÖwZ MÖvg cvDWv‡i Av‡Q c~biæ¾xweZ Ki‡Z Ges BD‡iU wµ÷vj RgvU (†fU)/†KwR ˆ`wnK IR‡bi Rb¨
euva‡Z evav cÖ`vb K‡i| Gw›Uev‡qvwUK A_ev A_ev 2.5 MÖvg/1 wjUvi cÖwZw`b 100 MÖvg
wmbj WweøDGmwc A¨v‡jvwcDwibj wewc 50 wg.MÖv.| Ab¨vb¨ Jla e¨env‡ii ci welv³Zv `~ixKi‡Y,
g~Îbvjxi †Kv‡l cÖ‡qvRbxq cywó mieiv‡ni gva¨‡g Lvevi cvwb‡Z wgwk‡q cici 3-5 w`b
g~Îbvjx‡K m‡ZR I cÖmvwiZ ivL‡Z| LvIqv‡Z n‡e|

EXPECTORANTS

gyiwMi R¡i, cÖ`vn I e¨_vbvkK wn‡m‡e Kvh©Ki|

cÖwZ wjUv‡i Av‡Q wdbvBj
Phenbrozole Sol. k¦vmZ‡š¿i Nb wgDKvm‡K Zij K‡i †ei K‡i mKj 1 wg.wj. 2 wjUvi Lvevi cvwb‡Z 100 wg.wj.
weDUvRb-50 MÖvg Ges †eªvg‡nw·b 500 wg.wj.
†db‡eªvRj mj. e¨vK‡Uwiqvj I fvBivj †iv‡Mi mnvqK wPwKrmvq wgwk‡q 7 w`b LvIqv‡Z n‡e|
nvB‡Wªv‡K¬vivBW-10 MÖvg| 1 wjUvi
Kvh©Ki|

cÖwZ wjUv‡i Av‡Q wfUvwgb G-8000
AvB.BD., wfUvwgb wm-1000 wg.MÖv.,
RESPIVAL Eucalyptus globulus 36000
wg.MÖv., Mentha piperita 24000
†imwcfvj
wg.MÖv., Thymus vulgaris 600 wg.MÖv.
I Bgvjwmdvqvi|
k¦vmZ‡š¿i mKj cÖKvi msµg‡Yi weiæ‡× Kvh©Ki|
k¦vmZ‡š¿i wgDKvm †gg‡eªb‡K myiÿv †`q| Lvgv‡i
ewa©Z A¨v‡gvwbqv, nvB‡Wªv‡Rb mvjdvBW I Wv‡÷i
cwigvY Kwg‡q k¦vmcÖk¦vm ¯^vfvweK iv‡L| ÿzavgv›`¨
`~i K‡i|
Lvevi cvwbi gva¨‡g: 1 wg.wj. 1
wjUvi Lvevi cvwb‡Z wgwk‡q cici
3-5 w`b| 500 wg.wj.
†¯úª c×wZ‡Z: 10 wg.wj. 1 wjUvi Lvevi
cvwb‡Z wgwk‡q cici 3-5 w`b|

ANTHELMINTICS

GwU GKwU Av`k© K…wgbvkK| †MvjK…wg (Ascaris 250 wg.MÖv./†KwR ˆ`wnK IR‡bi Rb¨ 10 × 10 MÖvg
Ascarzin Powder cÖwZ MÖv‡g Av‡Q cvBcvivwRb mvB‡UªU 1 sp. & Trichuris sp.) Gi weiæ‡× AwaK Kvh©Kix| A_ev 10 MÖvg 6-8 wjUvi Lvevi 100 MÖvg
GmKviwRb cvDWvi MÖvg (100%)| GQvovI mKj cÖvß eq¯‹ K…wgi weiæ‡× we‡kl fv‡e cvwb‡Z A_ev 3.5 †KwR Lv‡`¨| 500 MÖvg
KvR K‡i|

†cvwëª: 1 wg. wj. cÖwZ 25 †KwR ˆ`wnK

Mevw` cÖvYx I †cvwëªi AšÍtciRxex †hgb: IR‡bi Rb¨ cÖ‡qvM Ki‡Z n‡e|
Vermishin Solution cÖwZ wg.wj. †Z Av‡Q AvBfvi‡gKwUb cvK¯’jxi †MvjK…wg, †Pv‡Li K…wg, dzmdz‡mi K…wg, Mev`x cÖvYx: 1 wg. wj. cÖwZ 50 †KwR 100 wg.wj.
fvwg©wmb mwjDkb wewc 10 wg.MÖv.| ewntciRxex †hgb: AvuVvjx, gvBU, DKzb I gvwQi ˆ`wnK IR‡bi Rb¨ cÖ‡qvM Ki‡Z n‡e| 500 wg.wj.
Dc`ª‡e wb‡`©wkZ| Rjvkq ciRxex gy³ ivL‡Z 1 wjUvi
1 wg.wj./kZvsk (cÖwZ 1 dzU MfxiZvq)|

Mevw` cÖvYx I †cvwëªi AšÍtciRxex †hgb:

5 †dvUv/ †KwR ˆ`wnK IR‡bi Rb¨
Vermishin Pour On Sol. cÖwZ wg.wj. †Z i‡q‡Q AvBfvi‡gKwUb cvK¯’jxi †MvjK…wg, †Pv‡Li K…wg, dzmdz‡mi K…wg
Ges 14 w`b ci cybivq GKevi GKB 15 wg.wj.
fvwg©wmb †cvi Ab mwjDkb wewc 5 wg.MÖv.| Ges ewntciRxex †hgb: AvuVvjx, gvBU, DKzb I
gvÎvq cÖ‡qvM Ki‡Z n‡e|
gvwQi Dc`ª‡e wb‡`©wkZ|

Wormazole-100 Sol. cÖwZ wjUv‡i Av‡Q Gj‡ebWvRj 100 Gj‡ebWvRj mKj cÖKv‡ii K…wg‡K (wdZv K…wg, 0.1 wg.wj./†KwR ˆ`wnK IR‡bi 100 wg.wj.
Iqvgv©Rj-100 mwjDkb MÖvg| dzmdzm K…wg, †Mvj K…wg, hK…Z K…wg) aŸsm K‡i| Rb¨| 500 wg.wj

ANTICOCCIDIALS
gyiwMi AvB‡gwiqv †U‡bjv I AvB‡gwiqv †bKvwUª·
Gi weiæ‡× AwZgvÎvq Ges AvB‡gwiqv cÖwZ‡iva: 1 MÖvg 3 wjUvi Lvevi
Prolium-20 WSP cÖwZ MÖvg cvDWvi G Av‡Q Gg‡cÖvwjqvg Gmvifzwjbvi weiæ‡× ¯^ígvÎvq Kvh©Ki| GQvovI cvwb‡Z, 1-2 mßvn|
wPwKrmvq: 1 MÖvg 1-2 wjUvi Lvevi 100 MÖvg
†cÖvwjqvg-20 WweøDGmwc nvB‡Wªv‡K¬vivBW wewc 200 wg.MÖv.| UvwK©, KeyZi, cvwL, Miæ, QvMj, †fov, KzKzi Ges
weov‡ji i³ Avgvkq m„wóKvix wewfbœ cÖRvwZi cvwb‡Z, 5-7 w`b|
weiæ‡× Kvh©Ki|
cÖwZ †KwR‡Z Av‡Q
SI Coccine-Stop WSP G‡¤úªvwjqvg - 102 MÖvg Kw·wWIwmm †iv‡Mi weiæ‡× mvjdvKzB‡bv·vwjb I
GmAvBKKwmb-÷c mvjdvKzB‡bv·vwjb - 102 MÖvg G‡¤úªvwjqvg GK‡Î e¨env‡i wmbviwRmwUK 1 MÖvg 1 wjUvi Lvevi cvwb‡Z wgwk‡q 100 MÖvg
A¨vKkb Gi d‡j fv‡jv djvdj cvIqv hvq| 5-7 w`b|
WweøDGmwc wfUvwgb †K3 - 1 MÖvg

cÖwZ †KwR‡Z Av‡Q

G‡¤úªvwjqvg - 170 MÖvg Kw·wWIwmm †iv‡Mi weiæ‡× mvjdvKzB‡bv·vwjb I
Coccine-Stop WSP G‡¤úªvwjqvg GK‡Î e¨env‡i wmbviwRmwUK 1 MÖvg 1 wjUvi Lvevi cvwb‡Z wgwk‡q
mvjdvKzB‡bv·vwjb - 170 MÖvg 100 MÖvg
KKwmb-÷c WweøDGmwc A¨vKkb Gi d‡j fv‡jv djvdj cvIqv hvq| 5-7 w`b|
wfUvwgb †K3 - 1 MÖvg

Kw·wWIwmm †iv‡Mi Rb¨ `vqx AvB‡gwiqvi mKj 100 wg.wj

Cocci-Zione 25 Sol. 1 wg.wj. 1 wjUvi Lvevi cvwb‡Z
cÖwZ wjUv‡i Av‡Q UjUªvRywij 25 MÖvg| cÖRvwZi mKj ¯Í‡ii †Kvlxq ch©v‡q evav cÖ`vb K‡i 500 wg.wj.
KKwm-wRIb 25 mwjDkb wgwk‡q ci ci 2 w`b LvIqv‡Z n‡e|
Ges aŸsm K‡i| 1 wjUvi
 Product Portfolio
Jla Dcv`vb wb‡`©kbv gvÎv I cÖ‡qvMwewa mieivn
ANTIBIOTICS
k¦vmKó RwbZ mKj †ivM, gvB‡KvcøvR‡gvwmm /
CRD / CCRD, Kwje¨vwm‡jvwmm, G‡›UivBwUm,
Cipryl 20 WSP cÖwZ †KwR‡Z Av‡Q wm‡cÖvd¬·vwmb 200 Bb‡dKkvm KivBRv, Mvg‡ev‡iv, ivbx‡ÿZ mn 1 MÖvg 4 wjUvi Lvevi cvwb‡Z wgwk‡q
100 MÖvg
wmwcÖj 20 WweøDGmwc MÖvg| †h‡Kvb †m‡KÛvix e¨vK‡Uwiqvj Bb‡dKk‡b 3-5 w`b|
Kvh©Ki|

cwicvKZ‡š¿i msµgY (B. †KvjvB), G‡›UivBwUm,

cÖwZ MÖvg cvDWvi G Av‡Q A‡š¿i AbyRx‡ei †Mvj‡hvM, G‡UvwcK ivBbvBwUm,
Shinamycin WSP Aw·‡UUªvmvBwK¬b nvB‡Wªv‡K¬vivBW wewc GbRywUK wbD‡gvwbqv Ges wØZxq ch©v‡qi
1 MÖvg/wjUvi Lvevi cvwb‡Z,
100 MÖvg
wmbvgvBwmb WweøDGmwc 200 wg.MÖv.| e¨vK‡Uwiqvj Bb‡dKk‡b wmbvgvBwmb WweøDGmwc 3-7 w`b|
(†fU) e¨eüZ nq|
gyiMx-nuvm, QvMj, †fov Ges evQz‡i wbIgvBwm‡bi
cÖwZ MÖvg cvDWv‡i Av‡Q wbIgvBwmb Rb¨ ms‡e`bkxj e¨vK‡Uwiqv Øviv m„ó †hgb- B. 1 MÖvg/2-3 wjUvi cvwb‡Z 3-5 w`‡bi
Neoshin-50 WSP mvj‡dU wewc hv 500 wg.MÖv. †KvjvB, mvj‡gv‡bjv Gmwcwc Ges K¨v¤úvB‡jve¨v±i Rb¨ ev 20-30 MÖvg/100 †KwR Lv‡`¨ 100 MÖvg
wbIwmb-50 WweøDGmwc wbIgvBwmb Gi mgZzj¨| Gmwcwc e¨vK‡Uwiqvj G›UvivBwUm cÖwZ‡iva I 5-7 w`‡bi Rb¨ LvIqvb|
wPwKrmvi Rb¨ wb‡`©wkZ nq|
k¦vmKó RwbZ mKj †ivM, gvB‡KvcøvR‡gvwmm /
CRD / CCRD, Kwje¨vwm‡jvwmm, G‡›UivBwUm,
Cipryl Solution cÖwZ wjUv‡i Av‡Q wm‡cÖvd¬·vwmb 100 Bb‡dKkvm KivBRv, Mvg‡ev‡iv, ivbx‡ÿZ mn 1 wg.wj. 2 wjUvi Lvevi cvwb‡Z 100 wg.wj.
wmwcÖj mwjDkb MÖvg| †h‡Kvb †m‡KÛvix e¨vK‡Uwiqvj Bb‡dKk‡b wgwk‡q 3-5 w`b| 500 wg.wj.
Kvh©Ki|

Flotec 200 Solution cÖwZ wjUv‡i Av‡Q †d¬vi‡dwbKj 200 mvj‡gv‡b‡jvwmm, Kwje¨vwm‡jvwmm, G‡›UivBwUm, 1 wg.wj. 2 wjUvi Lvevi cvwb‡Z 100 wg.wj.
MÖvg| CRD /CCRD Ges Bb‡dKkvm KivBRvi weiæ‡× wgwk‡q 3-5 w`b|
†d¬v‡UK 200 mwjDkb KvR K‡i| 500 wg.wj.

Hytil Solution cÖwZ wjUv‡i Av‡Q wUjgvB‡Kvwmb gvB‡KvcøvR‡gvwmm /CRD /CCRD Gi weiæ‡× 1 wg.wj. 3 wjUvi Lvevi cvwb‡Z 100 wg.wj.
nvBwUj mwjDkb dm‡dU-250 MÖvg| AwaK Kvh©Kix| wgwk‡q 3-5 w`b| 500 wg.wj.

Norfloxillin 200 Sol. cÖwZ wjUv‡i Av‡Q bi‡d¬v·vwmb 200 dvDj K‡jiv, mvj‡gv‡b‡jvwmm, gvB‡KvcøvR‡gvwmm 1 wg.wj. 4 wjUvi Lvevi cvwb‡Z 100 wg.wj.
MÖvg| mn †h‡Kvb †m‡KÛvix e¨vK‡Uwiqvj Bb‡dKk‡b wgwk‡q 3-5 w`b|
bi‡d¬vw·wjb 200 mwjDkb 500 wg.wj.
Kvh©Ki|

Tia-Forte Solution cÖwZ wjUv‡i Av‡Q wUqvgywjb gvB‡KvcøvR‡gvwmm/CRD/CCRD, Avi_ªvBwUm Gi 1 wg.wj. 1 wjUvi Lvevi cvwb‡Z 100 wg.wj.
wUqv-†dvU© mwjDkb nvB‡Wªv‡Rb wdDgv‡iU 125 MÖvg| weiæ‡× KvR K‡i| wgwk‡q 3-5 w`b| 500 wg.wj.

FEED ADDITIVES & PROBIOTICS

cÖwZ †KwR‡Z Av‡Q ev‡qv cøvm Uz we-25 †cvwëª: 500 MÖvg-1 †KwR/ 1 Ub
MÖvg, (Bacillus licheniformis cwicvK ÿgZv evovq, A‡š¿i pH wbqš¿Y K‡i, wdW|
Bio-top CH-200... 4x1010 CFU/gm, `yM©Ügq Wvqwiqv cÖwZ‡iva K‡i, e¨vK‡Uwiqv I 1 †KwR
Miæ/gwnl/†Nvov/evQyi/†fov/QvMj: 20 †KwR
ev‡qv-Uc Bacillus subtilis CH 201...4x1010 QÎvK wbtm„Z wel †kvlY K‡i| 40-80 MÖvg Lv‡`¨i mv‡_ wgwk‡q
CFU/gm), wRsK A·vBW-20 MÖvg| LvIqv‡Z n‡e|

m¨vKv‡ivgvBwmm †mwiwfwm, A¨vwg‡bv D”P gvÎvi †gUv‡evjvBU, wfUvwgb we Ges eªqjvi, †jqvi, weªWvi, UvwK© Ges gvQ: (100 MÖvg
A¨vwmW (A¨vjvbvBb, †cÖvwjb, A¨vgvB‡bv GwmW mieivn K‡i| Lv`¨ MÖn‡bi nvi 1-1.5 †KwR/†gwUªK Ub wdW| x 5)
A-Max Xtra AviwRbvBb, A¨vmcvwU©K A¨vwmW, Ges Mo ‰`wnK e„w× DbœZ K‡i| ZvcRwbZ aK‡ji WªvB-KvD, j¨vK‡UwUs KvD: 20-25 500 MÖvg
G-g¨v· G·Uªv wm÷vBb, M¬vBwmb, wnw÷wWb), wfUvwgb mg‡q I cÖvYxi Drcv`b ¶gZv wVK iv‡L| Mevw` MÖvg/cÖvYx/w`b| Kvd ÷vU©vi: 4-5 MÖvg /
1 †KwR
we12, wgbv‡ij Ges Ab¨vb¨ cÖ‡qvRbxq cÖvYxi iæ‡gb †gUvewjRg e„w× K‡i| cÖvYx/w`b| eKbv: 8-12 MÖvg/cÖvYx/w`b|
QvMj/†fov: 1.5 MÖvg/cÖvYx/w`b| 25 †KwR
wfUvwgb I GbRvBg|
Lv‡`¨i Kvh©KvwiZv I iƒcvšÍ‡ii nvi e„w× K‡i,
Lv`¨ MÖn‡bi cwigvY I nRgkw³ e„w× K‡i,
LEVULYSE micron Saccharomyces cerevisiae DcKvix AbyRx‡ei cwigvY I Kvh©KvwiZv e„w× 1 wg.wj. 1 wjUvi Lvevi cvwb‡Z
1 wjUvi
wj‡fvjvBm gvBµb (Inactivated liquid yeast): 87% K‡i, ÿwZKi e¨vK‡Uwiqvi cwigvY nªvm K‡i wgwk‡q 5-7 w`b LvIqv‡Z n‡e|
cÖvYxi A‡š¿i cwi‡ek‡K DbœZ K‡i, ˆ`wnK IRb
e„wׇZ mnvqZv K‡i|

cÖwZ †KwR‡Z Av‡Q nRgkw³ I cywó †kvl‡Yi cwigvY e„w× K‡i|

SPEED-BIOTIC Bacillus subtilis 1.425 × 109 DcKvix e¨vK‡Uwiqv e„w×i gva¨‡g ÿwZKi 1 MÖvg 5 wjUvi Lvevi cvwb‡Z A_ev
w¯úW ev‡qvwUK CFU/gm, Oregano oil 1200 e¨vK‡Uwiqvi cwigvY n«vm K‡i b¨vPvivj 5 †KwR wd‡W wgwk‡q 5-7 w`b 5×100 MÖvg
mg, †W·‡Uªvm, g¨vj‡Uªv‡W·wUªb | Immunity †K e„w× K‡i| LvIqv‡Z n‡e|

1 wg.wj./ 20wjUvi Lvevi cvwb

SI AMOFREE-L BDKv wmwW‡Riv wbh©vm-50% Ges 100 wg.wj.
Gm AvB A¨v†gvd«x-Gj KzBjvRv m¨v‡cvbvwiqv cwigvY g‡Zv| †cvwëªi wjUvi I cvK¯’jxi A¨v‡gvwbqv M¨v‡mi †cvwëªi wjUv‡i: 80 wg.wj./1000 500 wg.wj.
eM©d‡z U mßv‡n 2 evi cÖ‡qvM Ki‡Z n‡e|
Dcw¯’wZ `~i K‡i| Lvev‡ii bvB‡Uªv‡Rb cwic~Y©
200 MÖvg/1000 evW©| cÖwZevi †m‡Wi
SI AMOFREE-P e¨envi wbwðZ K‡i Drcv`b e„w× K‡i|
BDKv wmwW‡Riv cvDWvi-50%| wjUvi cwieZ©‡bi mgq bZzb wjUvi Gi 100 MÖvg
Gm AvB A¨v†gvd«x-wc
mv‡_ wgwk‡q w`‡j Lvgvi A¨v‡gvwbqv gy³ nq
 Product Portfolio
Jla Dcv`vb wb‡`©kbv gvÎv I cÖ‡qvMwewa mieivn
INSECTICIDES & DISINFECTANTS
250 MÖvg
cvwb weï×KiY: 1 wU U¨ve‡jU (50U¨ve‡jU)
cÖwZ U¨ve‡jU (5 MÖvg) G Av‡Q cvwb RxevYygy³KiY I cvwbi GwmwWK pH eRvq
SI Chlor-T Tab †mvwWqvg WvB‡K¬vi AvB‡mv ivL‡Z e¨eüZ nq| GQvovI †k‡Wi †g‡S
250-500 wjUvi cvwb‡Z, †g‡S/ 500 MÖvg
GmAvB †K¬vi-wU U¨ve hš¿cvwZ weï×KiY: 1 wU U¨ve‡jU 5 (100U¨ve‡jU)
mvqvwbD‡iU 3.3 MÖvg| Rxevbygy³Ki‡Y I dzUev‡_ eûj e¨eüZ nq| 1 †KwR
wjUvi cvwb‡Z|
(200U¨ve‡jU)
20-25 MÖvg mv`v †cø‡U Qwo‡q cvwb
cÖwZ †KwR‡Z Av‡Q BwgWv‡K¬vwcÖW-20 Mevw` cÖvYx I †cvwëª Lvgv‡i gvwQi Dc`ªe wbim‡b
SI Flytrap-G MÖvg I gvmKv‡gvb cwigvY gZ|
wQwU‡q w`‡q ivL‡Z n‡e| cÖwZ 100
e¨envi Kiv nq| 100 MÖvg
GmAvB d¬vBUª¨vc-wR eM©dz‡Ui Rb¨ 20 MÖvg K‡i e¨envi
Ki‡Z n‡e|

LIVE VACCINES
1g †WvR 3-5 w`b eq‡m Ges ey÷vi
†WvR 18-22 w`b eq‡m 1 †Pv‡L 1
PoulShot® LaSota ivYx‡ÿZ †iv‡Mi fvBivm (†÷ªBb
ivYx‡ÿZ †ivM cÖwZ‡iv‡a e¨envi Kiv nq| 1000 †WvR
jv‡mvUv)| †duvUv †`qv nq| †jqvi I weªWvi dv‡g©
†cvjkU jv‡mvUv
cÖwZ 1-1.5 gvm ci ci Lvevi
cvwb‡Z wgwk‡q LvIqv‡Z n‡e|
1g †WvR 3-5 w`b eq‡m Ges ey÷vi
ivYx‡ÿZ †iv‡Mi fvBivm (†÷ªBb †WvR 18-22 w`b eq‡m 1 †Pv‡L 1
PoulShot® LaSota+IB jv‡mvUv) I eªsKvBwUm †iv‡Mi fvBivm ivYx‡ÿZ I eªsKvBwUm †ivM cÖwZ‡iv‡a e¨envi 1000 †WvR
†duvUv †`qv nq| †jqvi I weªWvi dv‡g©
†cvjkU jv‡mvUv+AvBwe (†÷ªBb H120)| Kiv nq| cÖwZ 1-1.5 gvm ci ci Lvevi
cvwb‡Z wgwk‡q LvIqv‡Z n‡e|
1g †WvR 3-5 w`b eq‡m Ges ey÷vi
ivYx‡ÿZ †iv‡Mi fvBivm (†÷ªBb B1) †WvR 18-22 w`b eq‡m 1 †Pv‡L 1
PoulShot® B1+IB ivYx‡ÿZ I eªsKvBwUm †ivM cÖwZ‡iv‡a e¨envi Kiv 1000 †WvR
I eªsKvBwUm †iv‡Mi fvBivm (†÷ªBb †duvUv †`qv nq| †jqvi I weªWvi dv‡g©
†cvjkU we1+AvBwe nq|
H120)| cÖwZ 1-1.5 gvm ci ci Lvevi
cvwb‡Z wgwk‡q LvIqv‡Z n‡e|
eqjvi/†jqvi/weªWvi/KK: 1g †WvR
Mvg‡ev‡iv †iv‡Mi fvBivm (†÷ªBb 7-10 w`b eq‡m Ges ey÷vi †WvR
PoulShot® Gumboro LZD 228-JAC3) B›UviwgwW‡qU Kgvwk©qvj eªqjvi, †jqvi I weªWv‡i Mvg‡ev‡iv †ivM 14-17 w`b eq‡m 1 †Pv‡L 1 †duvUv 1000 †WvR
†cvjkU Mvg‡ev‡iv UvBc f¨vKwmb| cÖwZ‡iv‡a e¨envi Kiv nq| w`‡Z n‡e ev Lvevi cvwb‡Z wgwk‡q
LvIqv‡Z n‡e|
eªqjvi: 7-10 w`b eq‡m Lvevi
Mvg‡ev‡iv †iv‡Mi fvBivm (†÷ªBb cvwb‡Z A_ev †Pv‡L 1 †duvUv K‡i
PoulShot® IBD Win+ DB›Uviwdì 2512) B›UviwgwW‡qU cøvm Kgvwk©qvj eªqjvi, †jqvi, KK I weªWv‡i Mvg‡ev‡iv cÖ‡qvM Ki‡Z n‡e| †jqvi: 1g †WvR 1000 †WvR
†cvjkU AvBwewW DBb+ UvBc f¨vKwmb| †ivM cÖwZ‡iv‡a e¨envi Kiv nq| 7-10 w`b eq‡m, 2q †WvR 14-17
w`b eq‡m Lvevi cvwb‡Z A_ev †Pv‡L
1 †duvUv K‡i|
1g †WvR: 0.2 wg.wj. K‡i 6-8
mßv‡n Nv‡oi Pvgovi wb‡P|
PoulShot® S/9R mvj‡gv‡bjv M¨vwj‡bivg (9R †÷ªBb)| mvj‡gv‡bjv M¨vwj‡bivg (dvDj UvBd‡qW) †ivM 1000 †WvR
2q †WvR: 0.2 wg.wj. K‡i 18
†cvjkU Gm/9Avi cÖwZ‡iv‡a e¨envi Kiv nq|
mßv‡n Nv‡oi Pvgovi wb‡P cÖ‡qvM
Ki‡Z n‡e|
1g †WvR: 6 mßv‡n †Pv‡L GK †duvUv/
PoulShot® MG-F gvB‡KvcøvRgv †Mwj‡mwÞKvg KvjPvi gvB‡KvcøvR‡gvwmm †iv‡Mi weiæ‡× cÖwZ‡ivaK Lvevi cvwb‡Z|
†cvjkU GgwR-Gd (†÷ªBb F810)| wn‡m‡e e¨envi Kiv nq| 2q †WvR: 9 mßv‡n †Pv‡L GK †duvUv/ 1000 †WvR
Lvevi cvwb‡Z wgwk‡q LvIqv‡Z n‡e|

KILLED VACCINES
wbw®Œq †n‡gvwdjvm c¨viv‡Mwj‡bivg cÖwZ gyiwM‡Z 0.5 wg.wj. K‡i ïaygvÎ †iwR÷vW© †f‡Uwibvwi wPwKrm‡Ki civgk© Abyhvqx e¨envh©
PoulShot® Coryza e¨vK‡Uwib †÷ªBb (Sub-type A & C) Kgvwk©qvj †jqvi I weªWv‡i KivBRv †ivM Bb‡RKk‡bi gva¨‡g gvs‡m 1g †WvR:
†cvjkU KivBRv wn‡m‡e e¨envi Kiv n‡q‡Q| cÖwZ‡iv‡a e¨envi Kiv nq| 6-8 mßv‡n eq‡m, ey÷vi †WvR: 1000 †WvR
G¨vWRy‡f›U wn‡m‡e A¨vjywgwbqvg 12-14 mßv‡n e¨envi Kiv nq|
nvB‡Wªv·vBW †Rj e¨envi Kiv n‡q‡Q|

ivYx‡ÿZ †iv‡Mi wbw¯Œq fvBivm 0.2 wg.wj Bb‡RKk‡bi gva¨‡g

PoulShot® NDO (†÷ªBb jv‡mvUv) GWRy‡f›U wn‡m‡e Kgvwk©qvj †jqvi I weªWvi G ivYx‡ÿZ †iv‡M gvs‡m A_ev Pvgovi wb‡P 35 w`b 1000 †WvR
†cvjkU GbwWI I‡qj e¨envi Kiv n‡q‡Q| cÖ w Z‡ivaK wn‡m‡e e¨envi Kiv nq|
eq‡m †`qv nq|

ivYx‡ÿZ †iv‡Mi fvBivm, Mvg‡ev‡iv Kgvwk©qvj †jqvi G 0.5 wg.wj. gvs‡m

Kgvwk©qvj †jqvi I weªWvi G ivYx‡ÿZ †ivM, 5-7 w`b eq‡m| weªWvi G 0.5 wg.wj.
PoulShot® ING-Plus †iv‡Mi wbw®Œq fvBivm I eªsKvBwUm
†cvjkU AvBGbwR-cøvm †iv‡Mi `yBwU wbw¯Œq fvBivm (†÷ªBb
eªsKvBvUm †ivM I Mvg‡ev‡iv †iv‡Mi cÖwZ‡ivaK gvs‡m cÖ_g †WvR 5-7 w`b eq‡m Ges 1000 †WvR
wn‡m‡e e¨envi Kiv nq| ey÷vi †WvR 16-18 mßvn eq‡m
M 41 I KM 91)|
cÖ‡qvM Ki‡Z n‡e|
GMWªc wmb‡Wªvg †iv‡Mi fvBivm
Kgvwk©qvj †jqvi I weªWvi G ivYx‡ÿZ †ivM, 15-18 mßvn eq‡mi gyiwM‡K 0.5
PoulShot® BNE (†÷ªBb EDS’ K11), ivYx‡ÿZ †iv‡Mi
eªsKvBwUm †ivM I GMWªc wmb‡Wªvg †iv‡Mi wg.wj. Bb‡RKk‡bi gva¨‡g gvs‡m 1000 †WvR
†cvjkU weGbB fvBivm (†÷ªBb jv‡mvUv) I eªsKvBwUm cÖ‡qvM Ki‡Z n‡e|
cÖwZ‡ivaK wn‡m‡e e¨envi Kiv nq|
†iv‡Mi fvBivm (†÷ªBb M 41)|

Corporate Office: 10/5-6, (Level-9) City Heart Building, 67-Naya Paltan, Dhaka-1000.
Tel: +880-2-48316468, +880-2-49357984, Fax : +880-2-48316512. Email: info@pf.com.bd, info@shinilpharma.com
12062023